Single-cell multi-omics work has mapped cancer-associated fibroblast (CAF) programs in triple-negative breast cancer (TNBC), identifying a myofibro-inflammatory signaling program that may drive tumor aggression. The study used high-resolution profiling to dissect stromal cell states and highlight potential therapeutic targets within the CAF compartment. By characterizing CAF heterogeneity at the single-cell level, researchers can separate which fibroblast programs align with specific functional outputs—such as inflammation-linked cues that can shape the tumor microenvironment. The reported analyses suggest actionable nodes within the program that could be explored for targeted intervention. For TNBC, where treatment options are limited and responses vary widely, CAF-focused strategies are increasingly seen as a route to complement direct tumor cytotoxicity. The study adds mechanistic detail that could guide future target validation and translational biomarker development.